May 19, 2017 - Human papillomavirus(HPV)-related head and neck cancer is recognized. Download Fulltext PDF. Review Article. Editor's Choice - Free Access. Kinzler KW, Myers JN: Exome sequencing of head and neck squamous cell. Jan 30, 2018 - Head and neck cancers are cancers that start in the tissues and organs of the head and neck. They include cancers of the larynx (voice box),.
The NCCN Guidelines for Head and Neck (H&N) Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the H&N, and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel’s discussion and most recent recommendations regarding evaluation and treatment of nasopharyngeal carcinoma. Disclosure of Relevant Financial Relationships All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support.
![Head and neck.org Head and neck.org](http://dxline.info/img/new_ail/head-and-neck-cancer.png)
All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity. The NCCN staff listed below discloses no relevant financial relationships: Kerrin M. Rosenthal, MA; Kimberly Callan, MS; Genevieve Emberger Hartzman, MA; Erin Hesler; Kristina M. Gregory, RN, MSN, OCN; Rashmi Kumar, PhD; Karen Kanefield; and Kathy Smith. INDIVIDUALS WHO PROVIDED CONTENT DEVELOPMENT AND/OR AUTHORSHIP ASSISTANCE: A.
Dimitrios Colevas, MD, Panel Member, has disclosed that he has received grant/research support from AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Cellsite; Innate Pharma S.A.; IRX Therapeutics, Inc.; Merck & Co., Inc.; Regeneron Pharmaceuticals, Inc.; Tessa Therapeutics Pte Ltd.; and Threshold Pharmaceuticals. He has also received consulting fees/honoraria and other financial benefit from Pfizer Inc. Yom, MD, PhD, Panel Member, has disclosed that she has received grant/research support from Genentech, Inc., Merck & Co., Inc., and Bristol-Myers Squibb Company. Pfister, MD, Panel Chair, has disclosed that he has received grant/research support from AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Eli Lilly and Company; Exelixis Inc.; Genentech, Inc.; GlaxoSmithKline; Incyte Corporation; MedImmune Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation. He has also received consulting fees/honoraria from Boehringer Ingelheim GmbH, Incyte Corporation, and Merck & Co., Inc. Sharon Spencer, MD, Panel Vice-Chair, has disclosed that she has no relevant financial relationships. Mittal, MD, Panel Member, has disclosed that he has no relevant financial relationships.
Ridge, MD, PhD, Panel Member, has disclosed that he has no relevant financial relationships. Burns, Guidelines Coordinator, NCCN, has disclosed that she has no relevant financial relationships. Darlow, PhD, Oncology Scientist/Medical Writer, NCCN, has disclosed that she has no relevant financial relationships. Disney junior games bunnytown. The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.